Your account is not claimed yet. You can sign up with ORCID to claim your account.

Eline Menu (E Menu)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 14

Top Venues

The Journal of pathology

Blood cancer journal

International journal of molecular sciences

Journal of experimental & clinical cancer research : CR

Vrije Universiteit Brussel

Vrije Universiteit Brussel (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vrije Universiteit Brussel Oct 1o 2007

Belgium

post-doc :: Hematology and Immunology

Education History

Vrije Universiteit Brussel

Belgium

PHD

Publications

Arne Van der Vreken, Inge Oudaert, Gamze Ates, Sylvia Faict, Philip Vlummens, Hatice Satilmis, Rong Fan, Anke Maes, Ann Massie, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Eline Menu
Metformin confers sensitization to syrosingopine in Multiple Myeloma cells by metabolic blockage and inhibition of protein synthesis. The Journal of pathology (2023)
Hui Zhang, Zhimin Du, Chenggong Tu, Xinyan Zhou, Eline Menu, Jinheng Wang
Hypoxic bone marrow stromal cells secrete miR-140-5p and miR-28-3p target SPRED1 to confer drug resistance in multiple myeloma. Cancer research (2023)
Eline Menu, Karin Vanderkerken
Exosomes in Multiple Myeloma: from bench to bedside. Blood (2022)
Hatice Satilmis, Emma Verheye, Philip Vlummens, Inge Oudaert, Niels Vandewalle, Rong Fan, Jennifer M Knight, Nathan De Beule, Gamze Ates, Ann Massie, Jerome Moreaux, Anke Maes, Elke De Bruyne, Karin Vanderkerken, Eline Menu, Erica K Sloan, Kim De Veirman
Targeting the β 2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism. The Journal of pathology (2022)
Inge Oudaert, Hatice Satilmis, Philip Vlummens, Wouter De Brouwer, Anke Maes, Dirk Hose, Elke De Bruyne, Bart Ghesquière, Karin Vanderkerken, Kim De Veirman, Eline Menu
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Emma Verheye, Jesús Bravo Melgar, Sofie Deschoemaeker, Geert Raes, Anke Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Damya Laoui, Kim De Veirman
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions. International journal of molecular sciences 23 (2) (2022)
Patrick Nylund, Alba Atienza Párraga, Jakob Haglöf, Elke De Bruyne, Eline Menu, Berta Garrido-Zabala, Anqi Ma, Jian Jin, Fredrik Öberg, Karin Vanderkerken, Antonia Kalushkova, Helena Jernberg-Wiklund
A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma. Cell death & disease 12 (2) (2021)
Esther A Zaal, Harm-Jan S de Grooth, Inge Oudaert, Pieter Langerhorst, Sophie Levantovsky, Gijs J J van Slobbe, Jeroen W A Jansen, Eline Menu, Wei Wu, Celia R Berkers
Targeting coenzyme Q10 synthesis overcomes bortezomib resistance in multiple myeloma. Molecular omics (2021)
Anke Maes, Ken Maes, Philip Vlummens, Hendrik De Raeve, Julie Devin, Vanessa Szablewski, Kim De Veirman, Eline Menu, Jérôme Moreaux, Karin Vanderkerken, Elke De Bruyne
Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma. Blood cancer journal 9 (12) (2019)
Siyang Yan, Niels Vandewalle, Nathan De Beule, Sylvia Faict, Ken Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Kim De Veirman
AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma. Cancers 11 (11) (2019)
Sylvia Faict, Joséphine Muller, Kim De Veirman, Elke De Bruyne, Ken Maes, Louise Vrancken, Roy Heusschen, Hendrik De Raeve, Rik Schots, Karin Vanderkerken, Jo Caers, Eline Menu
Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts. Blood cancer journal 8 (11) (2018)
Chaima El Arfani, Kim De Veirman, Ken Maes, Elke De Bruyne, Eline Menu
Metabolic Features of Multiple Myeloma. International journal of molecular sciences 19 (4) (2018)
Ken Maes, Bram Boeckx, Philip Vlummens, Kim De Veirman, Eline Menu, Karin Vanderkerken, Diether Lambrechts, Elke De Bruyne
The genetic landscape of 5T models for multiple myeloma. Scientific reports 8 (1) (2018)
M Favreau, Eline Menu, D Gaublomme, K Vanderkerken, S Faict, K Maes, E De Bruyne, S Govindarajan, M Drennan, S Van Calenbergh, X Leleu, L Zabeau, J Tavernier, K Venken, D Elewaut
Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myeloma. Leukemia 31 (12) (2017)

Eline Menu.css-eqlu8i{font-size:small;padding-left:4px;} (E Menu)

Publication Activity (10 Years)

Top Topics

Top Venues

Eline Menu (E Menu)